Here is what we can expect to find:
- Insights on Vienna’s characteristics as a prime business location for biotech, pharma and medtech companies provided by:
- Andreas Goppelt (Ottobock CTO and Managing Director at the Vienna subsidiary Ottobock Healthcare Products GmbH)
- Peter Llewellyn-Davies (CEO APEIRON Biologics AG)
- Eva Prieschl-Grassauer (CSO Marinomed Biotech AG)
- Barbara Rangetiner (General Manager at Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.)
- Harald Schnidar (CEO SCARLETRED Holding GmbH)
- Erich Tauber (CEO Themis Bioscience GmbH)
- Philipp von Lattorff (Managing Director at Boehringer Ingelheim RCV GmbH & Co KG)
- Facts and figures on the life sciences sector in Austria and Vienna
- Global players manufacturing drugs and medical devices in Austria
- A list of dedicated biotech companies in Vienna
- Recent news, including Marinomed’s IPO
- Information on LISAvienna’s free services
Enjoy reading!